EML4 and non-small cell lung carcinoma: Remarkably, significant reduction of sphere formation (SF) was seen under combinatorial treatment in all 5 investigated NSCLC cell lines irrespective of their EGFR, KRAS, EML4/ALK and LKB1 status.